Cargando…

Interleukin-6 mediated inflammasome activation promotes oral squamous cell carcinoma progression via JAK2/STAT3/Sox4/NLRP3 signaling pathway

BACKGROUND: Interleukin-6 (IL-6) has been reported to be critical in oral squamous cell carcinoma (OSCC). However, the set of pathways that IL-6 might activate in OSCC are not fully understood. METHODS: IL-6 and Sox4 expressions were first determined with RT-qPCR, ELISA, Western blot, or immunohisto...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiao, Li, Li, Xue, Cao, Peilin, Fei, Wei, Zhou, Hao, Tang, Na, Liu, Yi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069786/ https://www.ncbi.nlm.nih.gov/pubmed/35513871 http://dx.doi.org/10.1186/s13046-022-02376-4

Ejemplares similares

Suppression of NLRP3 Inflammasome by Erythropoietin via the EPOR/JAK2/STAT3 Pathway Contributes to Attenuation of Acute Lung Injury in Mice
por: Cao, Fei, et al.
Publicado: (2020)

Simultaneous Assessment of mTORC1, JAK/STAT, and NLRP3 Inflammasome Activation Pathways in Patients with Sarcoidosis
por: Kraaijvanger, Raisa, et al.
Publicado: (2023)

NLRP3 Inflammasome Inhibitor BAY-117082 Reduces Oral Squamous Cell Carcinoma Progression
por: Scuderi, Sarah Adriana, et al.
Publicado: (2021)

Interleukin-1 and the NLRP3 Inflammasome in Pericardial Disease
por: Vecchié, Alessandra, et al.
Publicado: (2021)

SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma
por: Li, Chunguang, et al.
Publicado: (2021)

Research Progress of Mitochondrial Mechanism in NLRP3 Inflammasome Activation and Exercise Regulation of NLRP3 Inflammasome
por: Zhang, Tan, et al.
Publicado: (2021)

The role of NLRP3 inflammasome in 5-fluorouracil resistance of oral squamous cell carcinoma
por: Feng, Xiaodong, et al.
Publicado: (2017)

Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH
por: Wan, Xingyong, et al.
Publicado: (2016)

The NLRP3 inflammasome – interleukin 1β axis in uveal melanoma
por: Correa, Victor S. M. C., et al.
Publicado: (2023)

Activation of NLRP3 inflammasome promotes the proliferation and migration of esophageal squamous cell carcinoma
por: Yu, Shuang, et al.
Publicado: (2020)

Suppression of NLRP3 Inflammasome by Dihydroarteannuin via the HIF‐1α and JAK3/STAT3 Signaling Pathway Contributes to Attenuation of Collagen-Induced Arthritis in Mice
por: Zhang, Mingying, et al.
Publicado: (2022)

Neutrophils Promote Tumor Progression in Oral Squamous Cell Carcinoma by Regulating EMT and JAK2/STAT3 Signaling Through Chemerin
por: Hu, Xiaoyuan, et al.
Publicado: (2022)

Periodontal Pathogens Promote Oral Squamous Cell Carcinoma by Regulating ATR and NLRP3 Inflammasome
por: Yao, Yufei, et al.
Publicado: (2021)

Downregulation of signal transduction and STAT3 expression exacerbates oxidative stress mediated by NLRP3 inflammasome
por: Bai, Hua, et al.
Publicado: (2018)

The trigger for pancreatic disease: NLRP3 inflammasome
por: Liu, Tianming, et al.
Publicado: (2023)

NLRP3 inflammasome: The rising star in cardiovascular diseases
por: Zheng, Yidan, et al.
Publicado: (2022)

EGR1 Enhances Lymphangiogenesis via SOX18-Mediated Activation of JAK2/STAT3 Pathway
por: Yang, Yi, et al.
Publicado: (2022)

Janus Kinase Inhibition Ameliorates Ischemic Stroke Injury and Neuroinflammation Through Reducing NLRP3 Inflammasome Activation via JAK2/STAT3 Pathway Inhibition
por: Zhu, Hua, et al.
Publicado: (2021)

Interleukin 27 is increased in carotid atherosclerosis and promotes NLRP3 inflammasome activation
por: Gregersen, Ida, et al.
Publicado: (2017)

Interleukin-1 and the NLRP3 inflammasome in COVID-19: Pathogenetic and therapeutic implications
por: Potere, Nicola, et al.
Publicado: (2022)

NLRP3 inflammasome triggers interleukin‐37 release from human monocytes
por: Gritsenko, Anna, et al.
Publicado: (2022)

The Role of Interleukin-17A and NLRP3 Inflammasome in the Pathogenesis of Graves’ Ophthalmopathy
por: Lin, Chih-Chung, et al.
Publicado: (2023)

Regulation of NLRP3 Inflammasome by Phosphorylation
por: Song, Nan, et al.
Publicado: (2018)

NLRP3 Inflammasome and Inflammatory Diseases
por: Wang, Zheng, et al.
Publicado: (2020)

SFTSV Infection Induced Interleukin-1β Secretion Through NLRP3 Inflammasome Activation
por: Liu, Jian-Wei, et al.
Publicado: (2021)

Inhibiting the NLRP3 Inflammasome
por: El-Sharkawy, Lina Y., et al.
Publicado: (2020)

NLRP3 inflammasome in endothelial dysfunction
por: Bai, Baochen, et al.
Publicado: (2020)

Role of NLRP3 Inflammasome in Rheumatoid Arthritis
por: Yin, Hui, et al.
Publicado: (2022)

Pharmacological Inhibitors of the NLRP3 Inflammasome
por: Zahid, Ayesha, et al.
Publicado: (2019)

Role of NLRP3 inflammasome activation in HCC cell progression
por: Dai, Bingling, et al.
Publicado: (2023)

Rubia cordifolia L. ameliorates DSS-induced ulcerative colitis in mice through dual inhibition of NLRP3 inflammasome and IL-6/JAK2/STAT3 pathways
por: Qin, Wei, et al.
Publicado: (2022)

Predominant Activation of JAK/STAT3 Pathway by Interleukin-6 Is Implicated in Hepatocarcinogenesis()()
por: Jung, In Hye, et al.
Publicado: (2015)

NLRP3 inflammasome activation is involved in manganese-induced immunotoxicity: Mn activates macrophage NLRP3 inflammasome
por: Ji, Jing, et al.
Publicado: (2021)

Novel Activity of ODZ10117, a STAT3 Inhibitor, for Regulation of NLRP3 Inflammasome Activation
por: Kang, Ju-Hui, et al.
Publicado: (2023)

Porphyromonas gingivalis-Induced NLRP3 Inflammasome Activation and Its Downstream Interleukin-1β Release Depend on Caspase-4
por: Ding, Pei-Hui, et al.
Publicado: (2020)

NLRP3 inflammasome is responsible for Hantavirus inducing interleukin-1β in THP-1 cells
por: Ye, Wei, et al.
Publicado: (2019)

STAT3 signal transduction through interleukin-22 in oral squamous cell carcinoma
por: NAHER, LUTFUN, et al.
Publicado: (2012)

Identification of a novel orally bioavailable NLRP3 inflammasome inhibitor
por: Agarwal, Sameer, et al.
Publicado: (2020)

Corrigendum: Role of NLRP3 inflammasome in rheumatoid arthritis
por: Yin, Hui, et al.
Publicado: (2023)

Exosomes Regulate NLRP3 Inflammasome in Diseases
por: Li, Zhangwang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_5a002qv66rkc042ilpo9miruja